Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the...
United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5813)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on May 25, 2024 10:56am
Ink Research
Morning Report: What is next for the freshly squeezed pharma shorts? May24, 2024 We expect regulators to publish Canadian short position data as of May 15th on Friday. If so
...more
(5813)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on May 25, 2024 7:35am
Keystone Financial
Pretty sure this is CPH. GLTA As you review your portfolio in 2024, we encourage you to ask yourself if it included the Best Performing Stock on the entire TSX over the past year? If
...more
Anfield Receives Drill Program Permit Application Approval for Slick Rock
posted Jun 17, 2024 9:00am by
Anfield Energy Inc
-
|
Corey Dias, Anfield’s CEO commented: “We are very pleased to commence development at Slick Rock as this project is integral to our hub-and-spoke uranium and vanadium production strategy. The 20-hole drill program, which will start during the third quarter of 2024, will allow us to both verify and upgrade our known resource at site and meet the criteria to secure a large mine permit from the appropriate agency. Our aim is to have both the ...read more
(5813)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on May 20, 2024 2:15pm
Earnings Assessment
What's not to like. GLTA EPS of 20c beat estimates of 10c; revenue of $5.86M beat estimates of $5.04M. EBITDA of $3.57M beat estimates of $3.23M. Licencing revenue rose 55%. EBITDA rose 12.5
...more
(5813)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on May 13, 2024 8:43am
Stifel
Clearly not a fan and was pretty much compelled to raise his target price. GLTA Citing valuation concerns with its shares up 85 per cent year-to-date (versus a 7-per-cent gain for the S&P/TSX
...more
(5813)
•••
retiredcf
X
View Profile
View Bullboard History
Comment by
retiredcf
on May 10, 2024 10:53am
RE:RE:RE:RE:RE:RE:Cipher Pharmaceuticals Reports Fourth Quarter
Smart move! GLTA
(42)
•••
Teccing
X
View Profile
View Bullboard History
Comment by
Teccing
on May 09, 2024 9:18am
RE:RE:RE:RE:RE:Cipher Pharmaceuticals Reports Fourth Quarter
Dipping my toe early
(1650)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on May 01, 2024 12:11pm
smallcapdiscoveries
https://www.youtube.com/watch?v=Ek0C9XfbYa4 The company discussed is Cipher. Interview with Dakota @LeftField_FHRS Smallcap Discoveries 5.05K subscribers
...more
(12)
•••
SushiGobbler
X
View Profile
View Bullboard History
Comment by
SushiGobbler
on May 01, 2024 12:04pm
RE:RE:RE:RE:Cipher Pharmaceuticals Reports Fourth Quarter
People are pricing in their Truclera nail fungus cream future potential sales i believe, which has been predicted to bring in tens/hundreds of millions in revenue annually potentially if all goes well
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 03, 2024 7:06am
New Press Release - Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre.Dates:Tuesday April 16...
read article.
(5813)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Apr 01, 2024 1:25pm
Volatile Market
Now back down to below where we were after the initial positive reaction to their earnings. Makes little sense other than the stock being firmly in the hands of momentum traders and/or stop losses
...more
(5813)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Mar 30, 2024 1:27pm
Comparison
Could you please compare and contrast CPH and VHI? Looking for key differences or attributes. Is one better than the other, or if starting a new position, would you just allocate funds 50/50? These
...more
(5813)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Mar 26, 2024 10:22am
Ryan Irvine
Go to the 17 min of the clip and he will tell you why he selected CPH back in September. It remains his first pick of three; for anyone interested, the other two are DNG and VBNK. GLTA https
...more
(5813)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Mar 23, 2024 1:06pm
Finally an Assessment
Results yesterday from CPH and DR both looked excellent and the stock prices have moved up significantly in response. They both look cheap, particularly CPH, even more so if you ex out the $2.20 cash
...more
(175)
•••
colourama
X
View Profile
View Bullboard History
Comment by
colourama
on Mar 21, 2024 1:53pm
RE:RE:RE:Cipher Pharmaceuticals Reports Fourth Quarter
Absolutely great results by CPH, but am I wrong in thinking this is getting expensive? 20x TTM free cash flow, 14x TTM EBITDA. I don't see where the growth is coming from to support the multiples,
...more
(5813)
•••
retiredcf
X
View Profile
View Bullboard History
Comment by
retiredcf
on Mar 20, 2024 2:50pm
RE:RE:RE:Cipher Pharmaceuticals Reports Fourth Quarter
Although I stiil haven't been able to find any analyst coverage, it seems safe to say that judging by the continued strength of the SP together with solid trading volume, they also liked what they
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A Low Cost Natural Gas Producer for Your Portfolio
A Junior Copper-Gold Stock Trading at a Bargain of Monumental Proportions